We only have this paper's title and publication details.
Read it at the sourceObservational analysis demonstrates prognostic value of circulating tumor DNA and PSA reduction in metastatic castration-resistant prostate cancer, highlighting enhanced treatment monitoring.
Prognostic value of on-treatment ctDNA TF detection and 30% PSA reduction
No takes yet. Share an insight, caveat, or question.
Sweeney et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: